Among other capabilities a global Fortune 500 group produces ingredients for dietary supplements and food and drink products. This business unit has been very successful, expanding at double digit growth rates and delivering strong profitability. The group believed they could build on this success by creating a new venture to develop pharmaceutical grade ingredients.
Our strategy experts helped the group:
The work now means the board is behind the effort to stake out new ground in pharmaceuticals. The company is investing tens of €millions in its programme to find the right research partners and carry out its own R&D.